Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights| Plasmid display technology physically couples each library member's genotype (DNA) to its phenotype (protein) through a stable, non-covalent DNA-binding fusion, enabling cell-free expression and immediate selection. This approach circumvents the laborious library construction and transformation bottlenecks of yeast display, the conformational epitope loss caused by phage coat-protein interference, and the avidity-driven false positives that plague multivalent systems. |
|
By enforcing strict monovalency and direct genotype-phenotype linkage, plasmid display allows precise off-rate and thermostability pressure to be applied from the very first round, enriching ultra-slow off-rate, thermostable variants that traditional platforms routinely miss. The result is a single, high-stringency kinetic screening workflow that intercepts lead-candidate failure before it reaches preclinical development.
Curious about integrating this platform into your research roadmap? Creative Biolabs offer tailored to your project demands.
Plasmid display achieves genotype-phenotype linkage by fusing the protein of interest to a high-affinity DNA-binding domain; the encoding plasmid remains physically tethered to the nascent protein during cell-free expression. This architecture eliminates the need for viral assembly or surface-anchoring in living cells, and it grants absolute control over valency (exactly one protein molecule per plasmid) thereby removing avidity bias and enabling true kinetic discrimination.
| Dimension | Plasmid Display | Phage Display | Yeast Display |
| Library diversity | 109 - 1010 (electroporation-driven cloning) | 109 - 1011 (high-efficiency packaging) | 107 - 109 (limited by yeast transformation) |
| Copy-number control | Strictly monovalent | Multivalent | Variable |
| Screening stringency | Kinetic control via inducible expression and copy-number tuning; near-monovalent display feasible | Limited kinetic control; polyvalent display predominates | FACS-based but variable copy number; bulky wall may obstruct antigen access |
| Conformational epitope preservation | Excellent - soluble, prokaryotic expression preserves delicate structures without glycosylation artefacts | Good, but phage-coat fusion may distort some epitopes | Good, although yeast-specific glycosylation can mask mammalian epitopes |
| Display-level uniformity (CV%) | Uniform 1:1 stoichiometry - minimal false positives | Heterogeneous display density, high CV, frequent false positives | Highly heterogeneous copy number, CV >50%, driving stochastic enrichment of non-specific binders |
Boasting orders-of-magnitude advantages in library capacity and precise kinetic selection tuning, plasmid display stands as the platform of choice for projects requiring ultra-deep sequence space sampling and isolation of rare functional binders.
The experimental progression is built around a minimal-step loop that feeds biophysical data directly into library design.
At the core of the workflow, precise copy-number control ensures a monovalent display that completely eliminates avidity bias. This allows off-rate discrimination to be translated into a quantitative sorting gate - clones that retain target engagement after an extended cold competitor wash are physically segregated and sequenced. The resulting NGS enrichment profiles close the loop, informing the design of subsequent focused libraries if finer kinetic tuning is required.
Five pillars define the decisive advantage of partnering with Creative Biolabs for plasmid display screening.
Each campaign is supported by a single, named specialist who communicates from initial library design through final data delivery, ensuring continuity and customized troubleshooting for every project.
Creative Biolabs has executed numerous plasmid display campaigns against high-value, difficult targets, accumulating deep knowledge in library construction strategies that maximize functional diversity while avoiding common display-efficiency pitfalls.
Proprietary protocols exploit precise control of plasmid copy number and induction kinetics, allowing researchers to dial in selection pressure and isolate binders with pre-defined off-rate characteristics. This directly addresses the common frustration of late-stage hit maturation failures.
Because we maintains all major display systems, hits identified by plasmid display can be seamlessly progressed into orthogonal platforms for affinity maturation or epitope confirmation without changing partner.
Leveraging standardized operational modules and precise process parameter control, Creative Biolabs ensure stable library production and highly reproducible screening results, helping clients eliminate redundant experimental consumption and substantially reduce overall R&D expenditures.
, Receive a Feasibility Report
The full range of display technologies is available for comparative screening, orthogonal validation, and tailored campaign design.
Robust platform for peptide and antibody fragment libraries; suited for targets that tolerate prokaryotic folding.
Entirely cell-free; ideal for ultra-large libraries and cytotoxic proteins.
Surface display on Gram-negative bacteria; useful for bacterial-binding assays and flow-cytometric sorting.
Native mammalian glycosylation and folding; optimal for full-length IgGs and complex multi-pass receptors.
Unsure which display system best matches a target's requirements? . An objective recommendation based on the target's conformation and kinetic demands will be provided.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
